Abbott, the global healthcare leader, launched its ‘Chakkar Ko Check Kar’ campaign in India to highlightanoften-overlooked balance disorder,vertigo, which affects close to 70 million people in India.Vertigo is a condition that can make people feel...
Antidote Technologies, a digital health firm that focuses on patient engagement to advance recruitment for clinical trials, and SEQSTER PDM Inc., the leading patient-centric healthcare technology company, declared an agreement to improve patient...
Get ready for the highly anticipated Cosmetics Ingredients Expo 2024, a premier event that will bring together the best minds and leading innovators in the cosmetics industry.
Ligand Pharmaceuticals, a biopharmaceutical company, delcared that it has forayed into a definitive contract to acquire APEIRON Biologics AG, which holds royalty rights to QARZIBA® (dinutuximab beta) for the treatment of high-risk neuroblastoma...
Biostar Pharma, Inc., the US subsidiary of Beijing Biostar Pharmaceuticals Co., Ltd. (Biostar), a synthetic biology-driven biopharma firm focused on the creation and marketing of innovative oncology drugs, declared that the US FDA had approved...
Innovative Biomedicals, Inc, a top notch biopharmaceutical organization that creates, manufactures and market great medications for the treatment of oncology, immune system, cardiovascular and metabolic, ophthalmology and other significant...
Roche, a leading pharmaceutical firm, declared the United States Food and Drug Administration (US FDA) has sanctioned the Vabysmo (faricimab) 6.0 mg single-dose prefilled syringe (PFS) for use in the treatment of neovascular or ‘wet’ age-related...
Genexine, a publicly traded clinical-stage Korean biopharmaceutical company dedicated to the discovery and development of novel biologics for the treatment of serious unmet medical needs, has announced a merger with EPD Biotherapeutics (EPD Bio)...
Pulsus Group intends to establish an AI-based pharma healthcare IT cluster in Ameenpur, Sangareddy district, Telangana, at a cost of Rs 300 crore with the potential to create approximately 50,000 jobs. Pulsus Group CEO and...
Quest Diagnostics, a medical laboratories firm, reported an agreement with OMERS to buy LifeLabs, a provider of community laboratory tests for a huge number of Canadians, for a worth of around CAN $1.35 billion (around USD $985 million), including...
, CDSCO.jpg)
